科技创新与诚信立企双轮驱动，七年跻身"国家级专精特新小巨人" 国家级"小巨人"企业的评审以其高标准、严要求而著称，旨在筛选出在特定领域掌握关键核心技术、创 新能力突出、市场占有率领先的"排头兵"。数据显示，这些"排头兵"的平均成立年限为17.7年，多数企 业需历经十余年深耕，方能迈过"小巨人"的门槛。逢时科技仅用7年就成功突围，大幅"刷新"了入选"小 巨人"企业的平均"年龄"。 逢时科技自成立起便将科技创新作为企业发展的核心驱动，累计获得知识产权49项，其中发明专利20 项，参与制定国家标准3项及团体标准9项，在行业内处于领先位置。除自主研发外，逢时科技积极与中 国药科大学、中国海洋大学、青岛大学等高校共建实验室与研究中心，聚焦磷虾磷脂全价值协同开发， 构建起"基础研究—技术攻坚—产业落地"的全链条创新生态。此外，通过海外收并购，逢时整合挪威前 沿的抗衰技术、引入德国磷脂导入技术和细胞营养技术等，加速抢占南极磷虾产业创新的制高点。 近日，工业和信息化部公布第七批国家级专精特新"小巨人"企业名单，逢时科技入选，成为山东省在本 批次海洋药物和生物制品领域中唯一上榜企业。此次入选，既是对逢时科技积极响应国家"向海问 ...

管理层分析了关节类药物持续增长的多重动力：首先，公司的氨糖产品在市场中占据领先地位，其疗效 获得了患者的广泛认可，这有助于推动销售增长；其次，产品进入集采，增加了产品的市场覆盖和竞争 力，尤其基药目录解限后增长显著；再者，公司通过持续的品牌宣传和市场推广活动，提升了产品知名 度和市场占有率；最后，随着人口老龄化和健康意识的提高，关节类药物的需求未来仍将持续增长。 诚意药业表示，未来公司将继续通过产品创新、市场拓展和品牌建设等多重举措，确保关节类药品作为 公司业绩支柱的长期作用。 在海洋医药领域，公司正通过建立系统的海洋药物开发平台，整合现有资源，如核心产品盐酸氨基葡萄 糖和鱼油系列，并拓展包括高纯度EPA（二十碳五烯酸）在内的海洋生物制药产品线，致力于开发更多 海洋源性药物。 公司透露，其大健康产业园的基础设施目前已全部建成。尤为重要的是，旗下二十碳五烯酸乙酯软胶囊 已正式获得国家药品监督管理局核准签发的化学药品4类《药品注册证书》。这一重要成果不仅拓展了 公司的产品矩阵，待未来产能完全释放后，公司将构建起从鱼油原料到制剂的一体化供应链，形成"原 料-保健食品-药品"的全产业链运营模式。 业绩数据显示，诚意药 ...

Core Insights - The company Tongshi Technology has been ranked 439th in the "Asia Brand 500" list for 2025, marking a rise of 17 positions from the previous year, and is the only brand in the marine pharmaceuticals and bioproducts sector to be included [1] - Tongshi Technology has maintained its position as the global leader in krill oil sales for two consecutive years, with its VIK brand also being the top-selling domestic brand in China for the same period [3] - The company has made significant investments in research and development, holding 49 intellectual property rights and participating in the formulation of 3 national standards and 9 group standards [4] Product Development and Market Expansion - Tongshi Technology has launched the world's first PQQ small molecule krill peptide, which has generated significant consumer interest [4] - The flagship product, Tongshi VIK blue hat krill oil, is the only domestic product certified for both "maintaining healthy blood lipid levels" and "enhancing immunity," and is now available in 57 Sam's Club locations nationwide [4] - The company's products have been exported to 22 countries and regions, including the UK, France, Germany, and New Zealand, enhancing its global influence [6] Consumer Trust and Quality Assurance - The company has achieved a 40% repurchase rate for its krill oil products, reflecting strong consumer loyalty and trust [6] - Tongshi Technology has established a state-of-the-art transparent production facility in Qingdao, featuring a fully automated production line and stringent quality control measures [6] - The company has successfully produced krill oil with a phospholipid content of 56% and a leak rate controlled to below 0.01%, ensuring consistent quality [6] Strategic Collaborations and Future Plans - The company has initiated strategic collaborations with global leaders in the krill industry and has received patent acceptance for new phospholipid-modified drugs aimed at anti-inflammatory and anti-tumor applications [7] - Tongshi Technology aims to strengthen innovation-driven development and deepen industry-academia-research cooperation to lead breakthroughs in marine pharmaceuticals and bioproducts [9]

Group 1 - The event showcased 240 major scientific achievements, focusing on the urgent needs in key areas such as artificial intelligence, high-end equipment manufacturing, and advanced new materials in Guangxi [1][2] - A total of 25 projects reached cooperation intentions, with a total signed amount of 88.75 million yuan, including 21 key projects that were signed on-site [1] - 65 cutting-edge scientific achievements were selected for physical display, while 240 achievements were simultaneously released online, providing new ideas and technical support for the development of Guangxi's advantageous and characteristic industries [1] Group 2 - The event was co-hosted by the Guangxi Zhuang Autonomous Region Science and Technology Department and the Guangzhou Branch of the Chinese Academy of Sciences, themed "CAS Enters Guangxi, Creating a Future" [2] - The aim was to deepen the scientific and technological innovation cooperation between the Chinese Academy of Sciences and Guangxi, injecting more innovative vitality into the high-quality development of industries [2]

Group 1 - The event held in Nanning, Guangxi, focused on the transformation of significant scientific achievements from the Chinese Academy of Sciences, with 21 key projects signed to enhance the high-quality development of Guangxi's industries [1][3] - The theme "Chinese Academy of Sciences Enters Guangxi, Creating a Future" highlights the collaboration between the Guangxi Science and Technology Department and the Guangzhou Branch of the Chinese Academy of Sciences, addressing urgent needs in artificial intelligence, high-end equipment manufacturing, and advanced new materials [3][5] - A total of 65 cutting-edge technological achievements were showcased at the event, with an additional 240 achievements released online, demonstrating the strong momentum technology provides for industrial upgrades in Guangxi [3][5] Group 2 - Four Guangxi enterprises and four research institutes from the Chinese Academy of Sciences presented their major technological achievements in fields such as artificial intelligence, biomanufacturing, new materials, and marine medicine, fostering deeper industry-academia-research collaboration [5] - The Guangxi Technology Achievement Transformation Fund was promoted at the event, aiming to provide financial support for the transformation of scientific achievements into production, thereby injecting momentum into Guangxi's industrial development [5]